FDA Adverse Event Malfunction Summary report: N

ASTP

MDR report key: 17250596 · Received July 3, 2023

Report

Report Number
1823260-2023-02160
Event Type
Malfunction
Date Received
July 3, 2023
Date of Event
June 12, 2023
Report Date
July 24, 2023
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CIT
UDI-DI
07613336121023
PMA / PMN Number
K951595
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE C503 ANALYZER SERIAL NUMBER WAS (B)(6). THE CUSTOMER NOTED THAT THE ASSAY USED WITH THE C503 ANALYZER USES PYRIDOXAL PHOSPHATE (PYP) ACTIVATION WHEREAS THE ASSAY USED WITH THE DXC 700 AU ANALYZER DOES NOT. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

CALIBRATION AND QC WERE ACCEPTABLE, THEREFORE, A GENERAL REAGENT OR INSTRUMENT ISSUE IS NOT SUSPECTED. THE INVESTIGATION DETERMINED THE EVENT WAS CONSISTENT WITH TWO DIFFERENT TESTS (ONE WITH PYRIDOXAL PHOSPHATE (PYP) ACTIVATION AND ONE WITHOUT PYP) BEING USED TO TEST THE PATIENT SAMPLE. ASSAYS WITH PYP SHOW HIGHER RESULTS COMPARED TO ASSAYS WITHOUT PYP. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Description of Event or Problem · 0

THE INITIAL REPORTER COMPLAINED OF A DISCREPANT HIGH RESULT FOR 1 PATIENT SAMPLE TESTED FOR ASPARTATE AMINOTRANSFERASE ACC. TO IFCC WITH PYRIDOXAL PHOSPHATE ACTIVATION (ASTP) ON A COBAS PRO C 503 ANALYTICAL UNIT COMPARED TO A DXC 700 AU ANALYZER. THE RESULT FROM THE C503 ANALYZER WAS 385 U/L. THE RESULT FROM A DXC 700 AU ANALYZER WAS 181.99 U/L. THE QUESTIONABLE RESULT WAS NOT REPORTED OUTSIDE OF THE LABORATORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
19990 ASTP NADH OXIDATION/NAD REDUCTION, AST/SGOT CIT ROCHE DIAGNOSTICS NA 70098801 07613336121023

Patients

Seq Age Sex Outcome Treatment
1 Unknown